Key stats
About Ark Genomic Revolution Ucits ETF AccumUSD
Home page
Inception date
Apr 12, 2024
Replication method
Synthetic
Dividend treatment
Capitalizes
Primary advisor
ARK Investment Management LLC
ISIN
IE000O5M6XO1
The investment objective of the Fund is to generate long term capital growth (5 years or more)
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Technology Services
Health Services
Stocks100.02%
Health Technology72.21%
Technology Services14.73%
Health Services13.07%
Bonds, Cash & Other−0.02%
Cash−0.02%
Stock breakdown by region
North America88.48%
Europe11.52%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
ARKG invests in stocks. The fund's major sectors are Health Technology, with 72.22% stocks, and Technology Services, with 14.73% of the basket. The assets are mostly located in the North America region.
ARKG top holdings are CRISPR Therapeutics AG and Tempus AI, Inc. Class A, occupying 9.26% and 8.86% of the portfolio correspondingly.
ARKG assets under management is 28.89 M EUR. It's risen 47.58% over the last month.
ARKG fund flows account for 21.85 M EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, ARKG doesn't pay dividends to its holders.
ARKG shares are issued by ARK Investment Management LP under the brand ARK. The ETF was launched on Apr 12, 2024, and its management style is Active.
ARKG expense ratio is 0.79% meaning you'd have to pay 0.79% of your investment to help manage the fund.
ARKG follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
ARKG invests in stocks.
ARKG price has risen by 24.29% over the last month, and its yearly performance shows a 21.28% increase. See more dynamics on ARKG price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 18.36% over the last month, showed a 23.62% increase in three-month performance and has increased by 12.90% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 18.36% over the last month, showed a 23.62% increase in three-month performance and has increased by 12.90% in a year.
ARKG trades at a premium (0.11%) meaning the ETF is trading at a higher price than the calculated NAV.